165 related articles for article (PubMed ID: 15750445)
1. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
Saracco P; Bertorello N; Farinasso L; Einaudi S; Barisone E; Altare F; Corrias A; Pastore G
J Pediatr Hematol Oncol; 2005 Mar; 27(3):141-4. PubMed ID: 15750445
[TBL] [Abstract][Full Text] [Related]
2. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
3. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
McNeer JL; Nachman JB
Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Bostrom BC; Sensel MR; Sather HN; Gaynon PS; La MK; Johnston K; Erdmann GR; Gold S; Heerema NA; Hutchinson RJ; Provisor AJ; Trigg ME;
Blood; 2003 May; 101(10):3809-17. PubMed ID: 12531809
[TBL] [Abstract][Full Text] [Related]
5. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
6. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
Ularntinon S; Tzuang D; Dahl G; Shaw RJ
Pediatrics; 2010 May; 125(5):e1241-5. PubMed ID: 20385646
[TBL] [Abstract][Full Text] [Related]
7. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.
Waber DP; McCabe M; Sebree M; Forbes PW; Adams H; Alyman C; Sands SA; Robaey P; Romero I; Routhier MÈ; Girard JM; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2013 Nov; 60(11):1785-91. PubMed ID: 23832430
[TBL] [Abstract][Full Text] [Related]
9. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
[TBL] [Abstract][Full Text] [Related]
10. Infectious toxicity of dexamethasone during all remission-induction chemotherapy: report of two cases and literature review.
Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
Pediatr Hematol Oncol; 2004; 21(1):27-35. PubMed ID: 14660304
[TBL] [Abstract][Full Text] [Related]
11. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
Eiser C; Davies H; Jenney M; Stride C; Glaser A
Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
[TBL] [Abstract][Full Text] [Related]
12. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
13. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
15. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Liu H; Chen L; Nicoletti M; Stork L; Bostrom B; Neglia JP
Blood; 2009 Aug; 114(9):1746-52. PubMed ID: 19546477
[TBL] [Abstract][Full Text] [Related]
16. Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
Van Dongen-Melman JE; Hokken-Koelega AC; Hählen K; De Groot A; Tromp CG; Egeler RM
Pediatr Res; 1995 Jul; 38(1):86-90. PubMed ID: 7478803
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Rix M; Birkebaek NH; Rosthøj S; Clausen N
J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
19. Acute onset of obsessive-compulsive disorder in an adolescent with acute lymphoblastic leukemia.
Morris DR; Meighen KG; McDougle CJ
Psychosomatics; 2005; 46(5):458-60. PubMed ID: 16145191
[No Abstract] [Full Text] [Related]
20. Glucocorticoid withdrawal - heterozygous carriers of congenital adrenal hyperplasia at risk?
Brackmann F; Dörr HG; Bartram CR; Hinderhofer K; Holter W; Langer T
Klin Padiatr; 2012 Oct; 224(6):392-3. PubMed ID: 22915453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
